Your browser doesn't support javascript.
loading
Patient Heterogeneity in Health Economic Decision Models for Chronic Obstructive Pulmonary Disease: Are Current Models Suitable to Evaluate Personalized Medicine?
Hoogendoorn, Martine; Feenstra, Talitha L; Asukai, Yumi; Briggs, Andrew H; Borg, Sixten; Dal Negro, Roberto W; Hansen, Ryan N; Jansson, Sven-Arne; Leidl, Reiner; Risebrough, Nancy; Samyshkin, Yevgeniy; Wacker, Margarethe E; Rutten-van Mölken, Maureen P M H.
Affiliation
  • Hoogendoorn M; Institute for Medical Technology Assessment, Erasmus University Rotterdam, Rotterdam, The Netherlands. Electronic address: hoogendoorn@imta.eur.nl.
  • Feenstra TL; Department for Prevention and Health Services Research, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands; Department of Epidemiology, University Medical Centre Groningen, Groningen, The Netherlands.
  • Asukai Y; IMS Health, Health Economics and Outcomes Research and Real-World Evidence Solutions, London, UK.
  • Briggs AH; Institute of Health & Wellbeing, University of Glasgow, Glasgow, UK.
  • Borg S; The Swedish Institute for Health Economics, Lund, Sweden; Health Economics Unit, Department of Clinical Sciences in Malmö, Lund University, Lund, Sweden; Evidera, London, UK.
  • Dal Negro RW; National Center for Respiratory Pharmacoeconomics and Pharmacoepidemiology (CESFAR), Verona, Italy.
  • Hansen RN; Pharmaceutical Outcomes Research and Policy Program, School of Pharmacy, University of Washington, Seattle, WA, USA.
  • Jansson SA; Department of Public Health and Clinical Medicine, Occupational and Environmental Medicine, The OLIN Unit, Umeå University, Umeå, Sweden.
  • Leidl R; Helmholtz Zentrum München, Institute of Health Economics and Health Care Management, Member of the German Center for Lung Research, Comprehensive Pneumology Center Munich, Neuherberg, Germany.
  • Risebrough N; ICON Health Economics, Toronto, Ontario, Canada.
  • Samyshkin Y; IMS Health, Health Economics and Outcomes Research and Real-World Evidence Solutions, London, UK.
  • Wacker ME; Helmholtz Zentrum München, Institute of Health Economics and Health Care Management, Member of the German Center for Lung Research, Comprehensive Pneumology Center Munich, Neuherberg, Germany.
  • Rutten-van Mölken MPMH; Institute for Medical Technology Assessment, Erasmus University Rotterdam, Rotterdam, The Netherlands.
Value Health ; 19(6): 800-810, 2016.
Article in En | MEDLINE | ID: mdl-27712708
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Decision Making / Economics, Medical / Precision Medicine Type of study: Health_economic_evaluation / Prognostic_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Year: 2016 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Decision Making / Economics, Medical / Precision Medicine Type of study: Health_economic_evaluation / Prognostic_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Year: 2016 Type: Article